"There is a global revolution happening in the food industry, now is the time to be an innovation leader in the future of food, or support those who are"
(Andrew D. Ive , Big Idea Ventures)
Changing the way we eat must surely be the biggest challenge facing agri-food business at the moment and success has moved from moral choice to societal need."
(Tim Finnigan, Quorn)
If we assume that it is unlikely that most people will give up on meat, we will need modern technologies to provide sustainable solutions to feed the growing world population that has increased demands for meat products."
It is very clear that a considerable portion of our protein is consumed through products from animal origin. This consumption is one of the key factors causing current routes for food production to be insufficiently efficient to feed the growing, and more affluent world population. Meat production is inefficient with respect to the use of land, water and raw materials and it has serious impact on the environment. With a growing world population and a global rise in demand for meat, we need to make a transition to high quality protein-rich alternative food sources, while simultaneously considering human health and environmental sustainability.
There are several routes to follow, but this conference will focus on the two major alternatives, looking at the short and the long term:
Plant based proteins
Cell based Meat
The conference focuses on cutting edge research on one hand and on commercial initiatives on the other hand in its different forms and gathers experts from academia and industry to show their latest results and showcase their products and services.
The following topics will be covered during the conference:
R&D on supporting technologies like Biofabrication, 3D Printing, 3D Bioprinting etc.
R&D on cell structure, taste, texture, flavor, color, nutritional value, muscle structure etc.
Life Cycle Analysis (LCA)
Impact on agriculture industry
Social impacts cultured food (consumer adoption, society, economy)
Patent / Legal and Regulatory issues
This conference is related to the following conferences:
The 3D printing technology will be fundamental to the way people interact with food in the future. Supermarkets are already testing to 3D print customized cakes, caterers / restaurants are offering printed desserts. Some even claim that there will be a 3D food printer in every home soon. However, much research is required to change the hype into reality. Which industries will be influenced by the technology? Which food components can be printed in the near future? And which aspects should be taken into account to ensure safety and maintainability of 3D printed food?
How can innovation in nutrition help to improve the well being of the growing and ageing population in the world? With a growing and ageing population worldwide, the importance of healthy nutrition is of paramount importance. The impact of technology requires a cross-sector knowledge exchange and cooperation. The Healthy Nutrition Conference brings the food industry, retailers, foodservice providers, government and those working in nutrition, together to enable collaboration and innovation and to support a sustainable healthy nutrition landscape for the future.
3D Bioprinting is the utilization of 3D printing and 3D printing–like techniques to combine cells, growth factors, and biomaterials to fabricate biomedical parts that maximally imitate natural tissue characteristics. 3D Bioprinting holds much promise in advancing medicine as tool to replicate cellular complexity of tissue environment, ex vivo for drug screening and as a means of engineering well-defined functional tissue units for transplantation (scaffolds, which can be used to regenerate joints and ligaments).
3D printing is making a name for itself in medicine manufacturing. While it’s hard to foresee the wholesale replacement of current tablet manufacturing processes, 3D printing is expected to find a place in certain niche medications and in personalised tablets. For so-called orphan drugs, the inherent versatility of 3D printing is particularly appealing. Rather than the current situation of pharmaceutical companies needing to maintain expensive specialist infrastructure to manufacture medicines of which low numbers are sold, it is theoretically possible to print many different types of tablets by simply changing the powder used, or even by just changing the ‘ink cartridges’ in commercially available 3D printers.